ARCHIVES

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Women’s Health Trial RFPs Issued; Three Clinical Centers Sought

April 12, 1991

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

NCI Doesn’t Indicate Willingness To Review Large Programs As BSA Recommends. “We’re Celebrating Success,” NCI Director von Eschenbach Says. Intramural Program Isn’t Delivering What It Should, Margaret Tempero Says.

March 31, 2006

Institutions Required To Review For Bias under PHS Proposal

July 22, 1994

NCI Biostatistician Calls For Reanalysis Of Canadian Breast Screening Study

February 10, 1995

Call to Shift Two-Thirds Of Funds a “Rubber Number,” Bailar Says

June 6, 1997